STROKE PREVENTION IN NON-VALVULAR ATRIAL FIBRILLATION: SYSTEMATIC REVIEW OF COST-EFFECTIVENESS STUDIES

被引：1
|
作者：
Costa, S. [1 ]
Ramos, J. C. [1 ]
Braga, A. C. [1 ]
Pereira, J. [1 ]
机构：
[1] Univ Nova Lisboa, Natl Sch Publ Hlth, P-1200 Lisbon, Portugal
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 07期
关键词：
D O I：
10.1016/j.jval.2013.08.1311
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A531 / A531
页数：1
相关论文
共 50 条
  • [1] A Systematic Literature Review on the Cost-Effectiveness of Apixaban for Stroke Prevention in Non-valvular Atrial Fibrillation
    Pinyol C.
    Cepeda J.M.ª
    Roldan I.
    Roldan V.
    Jimenez S.
    Gonzalez P.
    Soto J.
    [J]. Cardiology and Therapy, 2016, 5 (2) : 171 - 186
  • [2] Cost-effectiveness of Dabigatran for Stroke Prevention in Non-valvular Atrial Fibrillation in Spain
    Gonzalez-Juanatey, Jose R.
    Alvarez-Sabin, Jose
    Lobos, Jose M.
    Martinez-Rubio, Antoni
    Reverter, Joan C.
    Oyagueez, Itziar
    Gonzalez-Rojas, Nuria
    Becerra, Virginia
    [J]. REVISTA ESPANOLA DE CARDIOLOGIA, 2012, 65 (10): : 901 - 910
  • [3] COST-EFFECTIVENESS OF DABIGATRAN FOR THE PREVENTION OF STROKE IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION IN AUSTRALIA
    Tilden, D.
    Germanos, P.
    Gordon, J.
    Tocchini, L.
    Monz, B.
    [J]. VALUE IN HEALTH, 2011, 14 (07) : A375 - A375
  • [4] COST-EFFECTIVENESS OF RIVAROXABAN IN THE PREVENTION OF STROKE IN NON-VALVULAR ATRIAL FIBRILLATION PATIENTS IN ITALY
    Capri, S.
    Veneziano, M.
    Ricciardi, W. G.
    D'Ausilio, A.
    Pedone, M. P.
    Bianchi, C.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A525 - A526
  • [5] Cost-effectiveness of apixaban for stroke prevention in non-valvular atrial fibrillation in Saudi Arabia
    Hersi, Ahmad S.
    Osenenko, Katherine M.
    Kherraf, Sid Ahmed
    Aziz, Ayman Abdel
    Sambrook, Robert Joseph
    [J]. ANNALS OF SAUDI MEDICINE, 2019, 39 (04) : 265 - 278
  • [6] Cost-effectiveness of apixaban compared to edoxaban for stroke prevention in non-valvular atrial fibrillation
    Lip, G. Y. H.
    Kongnakorn, T.
    Lanitis, T.
    Phatak, H.
    Liu, J. X. C.
    Kuznik, A.
    Lawrence, J.
    Dorian, P.
    [J]. EUROPEAN HEART JOURNAL, 2014, 35 : 1108 - 1109
  • [7] Cost-Effectiveness of Novel Oral Anticoagulants for Stroke Prevention in Non-Valvular Atrial Fibrillation
    Sheldon M. Singh
    Harindra C. Wijeysundera
    [J]. Current Cardiology Reports, 2015, 17
  • [8] Cost-Effectiveness of Novel Oral Anticoagulants for Stroke Prevention in Non-Valvular Atrial Fibrillation
    Singh, Sheldon M.
    Wijeysundera, Harindra C.
    [J]. CURRENT CARDIOLOGY REPORTS, 2015, 17 (08)
  • [9] COST-EFFECTIVENESS OF RIVAROXABAN FOR THE PREVENTION OF STROKE IN PATIENTS WITH NON-VALVULAR ATRIAL FIBRILLATION - A MULTINATIONAL STUDY
    Asukai, Y.
    Maniadakis, N.
    Carcedo, D.
    Lukac, M.
    Evers, T.
    [J]. VALUE IN HEALTH, 2013, 16 (03) : A285 - A285
  • [10] Edoxaban versus warfarin for stroke prevention in non-valvular atrial fibrillation: a cost-effectiveness analysis
    Rognoni, Carla
    Marchetti, Monia
    Quaglini, Silvana
    Liberato, Nicola Lucio
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2015, 39 (02) : 149 - 154
12345